Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Livatag vs BSC in Advanced HCC
NCT01655693Phase 3Completed
- Sponsor
- Valerio Therapeutics
- Start
- Jun 2012
- Primary completion
- May 2017
- Modality
- Nanoparticles, Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of Livatag in hepatocellular carcinoma (HCC), sponsored by Valerio Therapeutics. Started Jun 2012; status: completed.
02
Drugs
Livatag
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01655693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01655693.